Correlation Between GlaxoSmithKline PLC and Sit U
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Sit U at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Sit U into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Sit U S, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Sit U and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Sit U. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Sit U.
Diversification Opportunities for GlaxoSmithKline PLC and Sit U
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and Sit is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Sit U S in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sit U S and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Sit U. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sit U S has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Sit U go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Sit U
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Sit U. In addition to that, GlaxoSmithKline PLC is 6.17 times more volatile than Sit U S. It trades about -0.3 of its total potential returns per unit of risk. Sit U S is currently generating about 0.14 per unit of volatility. If you would invest 1,022 in Sit U S on August 30, 2024 and sell it today you would earn a total of 7.00 from holding Sit U S or generate 0.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Sit U S
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Sit U S |
GlaxoSmithKline PLC and Sit U Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Sit U
The main advantage of trading using opposite GlaxoSmithKline PLC and Sit U positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Sit U can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sit U will offset losses from the drop in Sit U's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Sit U vs. Tcw Total Return | Sit U vs. Ridgeworth Seix Government | Sit U vs. Short Duration Income | Sit U vs. Thompson Bond Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |